SpineAlign Medical Inc. is an early-stage medical device company focused on developing innovative, minimally invasive products to treat spinal disorders. The company primarily serves patients suffering from vertebral compression fractures, often associated with osteoporosis. Operating in the medical device market, SpineAlign's business model revolves around the research, development, and commercialization of advanced spinal implants. Their flagship product, the VerteLift Implant, is designed to enhance the treatment of thoracic and lumbar spine fractures. This implant is made from nitinol, a material known for its flexibility and strength, and is currently CE marked and commercially available in Europe. However, it is not yet available for sale in the United States as it is undergoing an Investigational Device Exemption (IDE) Trial. SpineAlign generates revenue through the sale of its implants and aims to expand its product portfolio to address emerging clinical needs in spinal treatment.

Keywords: spinal implants, vertebral compression fractures, osteoporosis, minimally invasive, nitinol, CE marked, IDE Trial, medical device, Europe, innovation.